May 3, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: INmune Bio Inc. (the “Company”) Registration Statement on Form S-3 File No. 333-254221 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. on May 5, 2021 or as soon thereafter as is practicable.
| Very truly yours, | ||
| INMUNE BIO INC. | ||
| By: | /s/ David Moss | |
| David Moss | ||
| Chief Financial Officer | ||